Labrys Biologics · Domain Security

Labrys Biologics Domain Security

Domain security

Domain security posture for Labrys Biologics, probed live across 2 host(s) and 1 registrable domain(s). Email/DNS controls: DNSSEC absent, SPF present, DMARC present (p=reject).

CompanyBiotechnologyPharmaceuticalsLife SciencesTherapeuticsNeurologyClinical ResearchAcquired

Transport & Host Security

labrysbiologics.com
HTTPS: no · HSTS: no
labrysbio.com
HTTPS: no · HSTS: no

Domain (DNS/Email) Security

labrysbiologics.com
DNSSEC: no · SPF: yes · DMARC: yes (p=reject) · CAA: none

Source

Domain Security

labrys-biologics-domain-security.yml Raw ↑ 
generated: '2026-07-19'
method: probed
source: live DNS/TLS/HTTP probes of the registrant domain labrysbiologics.com
note: >-
  labrysbiologics.com resolves but serves nothing — TCP 80 and 443 are both closed, so no
  TLS/HSTS posture can be observed. The domain is a defended brand registration held under
  Teva nameservers (ns3/ns4/ns5.tevapharm.com) following Teva's 2014 acquisition of Labrys
  Biologics. The mail posture is a deliberate no-mail lockdown: SPF "v=spf1 -all" and DMARC
  p=reject with aggregate reports routed to dmarc.RUA@tevapharm.com.
hosts:
- host: labrysbiologics.com
  https: false
  http_port_80: closed
  https_port_443: closed
  resolves: true
  a_record: 192.115.248.118
  hsts: null
- host: labrysbio.com
  https: false
  http_port_80: closed
  https_port_443: closed
  resolves: true
  a_record: 192.115.248.118
  hsts: null
domains:
- domain: labrysbiologics.com
  dnssec: false
  caa: []
  spf: true
  spf_record: v=spf1 -all
  dmarc: true
  dmarc_policy: reject
  dmarc_rua: dmarc.RUA@tevapharm.com
  nameservers:
  - ns3.tevapharm.com
  - ns4.tevapharm.com
  - ns5.tevapharm.com
  registrar: Nom-iq Ltd. dba COM LAUDE
  registrant_organization: Labrys Biologics
  created: '2012-12-09'
  expires: '2026-12-09'